Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, Efficacy and Pharmacodynamics of KBSA301 in Severe Pneumonia (S. Aureus)

NCT01589185 is registered in ClinicalTrials.gov with Aridis Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01589185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01589185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, Efficacy and Pharmacodynamics of KBSA301 in Severe Pneumonia (S. Aureus)
Lead sponsor
Aridis Pharmaceuticals, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2012
Completion date
September 30, 2016
Enrollment
48 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia due to staphylococcus aureus